Cargando…
Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models
SIMPLE SUMMARY: We examined the expression of SDF1α and its cognate receptor CXCR4 in human prostate cancer (PCa) lesions and the impact of CXCR4 inhibition alone and in combination with single-dose irradiation in orthotopic PCa models in mice. Both SDF1α and CXCR4 were highly expressed in primary a...
Autores principales: | Gupta, Nisha, Ochiai, Hiroki, Hoshino, Yoshinori, Klein, Sebastian, Zustin, Jozef, Ramjiawan, Rakesh R., Kitahara, Shuji, Maimon, Nir, Bazou, Despina, Chiang, Sarah, Li, Sen, Schanne, Daniel H., Jain, Rakesh. K., Munn, Lance L., Huang, Peigen, Kozin, Sergey V., Duda, Dan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954510/ https://www.ncbi.nlm.nih.gov/pubmed/36831366 http://dx.doi.org/10.3390/cancers15041021 |
Ejemplares similares
-
Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers
por: Kozin, Sergey V., et al.
Publicado: (2017) -
Flow-induced HDAC1 phosphorylation and nuclear export in angiogenic sprouting
por: Bazou, Despina, et al.
Publicado: (2016) -
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors
por: Chen, Yunching, et al.
Publicado: (2017) -
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
por: Shigeta, Kohei, et al.
Publicado: (2020) -
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model
por: Li, Wende, et al.
Publicado: (2021)